Aspirin and clopidogrel in patients with ACS undergoing PCI: CURE and PCI-CURE

Journal of Invasive Cardiology

Volumn 15, Issue SUPPL. B, 2003, Pages

  Mehta, Shamir R ^a,b   Ellis, Stephen ^b   Rapaport, Elliot ^b   Cannon, Chris ^b  

^a HAMILTON HEALTH SCIENCES   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN;

BLEEDING; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0037347361     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (11)

1. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502.
2. Budaj A, Yusuf S, Mehta SR, et al. Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. Circulation 2002;106:1622-1626.
3. Mehta SR, Yusuf S, Peters RJ, et al. Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE Study. Lancet 2001;358:527-533.
4. Mehta SR, et al., for the CURE Trial Investigators. PCI-CURE. Overall results long-term: CV death of MI. Lancet 2001;21:2033-2041.
5. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 Guideline update for the management of patients with unstable angina and Non-ST-segment elevation myocardial infarction - Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 2002;40:1366-1374.
6. Van Domburg RT, et al. Long-term clinical outcomes following PTCA. Eur Heart J 2001;22:934-941.
7. Bachmann F, et al. Rapid platelet inhibition of clopidogrel 375 mg loading dose (abstr). Eur Heart J 1996;17(Suppl):263.
8. Mehta SR, et al., for the CURE Trial Investigators. PCI-CURE. Long term outcomes after PCI. Lancet 2001;21:2033-2041.
9. Mehta SR, et al., for the CURE Trial Investigators. PCI-CURE. CV death or MI at various intervals. Lancet 2001;21:2033-2041.
10. Mehta SR, et al., for the CURE Trial Investigators. Bleeding and GP IIb/IIIa antagonists. Lancet 2001;21:2033-2041.
11. Mehta SR, et al., for the CURE Trial Investigators. PCI-CURE. CV death or MI from rand. to end. Lancet 2001;21:2033-2041.